当前位置:首页 - 行情中心 - 康芝药业(300086) - 财务分析 - 现金流量表

康芝药业

(300086)

  

流通市值:38.52亿  总市值:39.78亿
流通股本:4.41亿   总股本:4.55亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金403,323,943.49278,668,540.85122,821,964.09679,826,327.52
  收到的税费返还92,567.6765,352.0656,095.72151,328.2
  收到其他与经营活动有关的现金112,694,040.42105,833,711.3982,124,678.273,331,971.59
  经营活动现金流入小计516,110,551.58384,567,604.3205,002,738.01753,309,627.31
  购买商品、接受劳务支付的现金121,559,688.9788,816,805.4250,624,762.09209,518,089.77
  支付给职工以及为职工支付的现金61,123,592.2241,553,881.9222,000,908.6284,840,184.05
  支付的各项税费29,520,192.9220,319,442.8712,619,721.6364,736,011.63
  支付其他与经营活动有关的现金246,728,453.04167,524,978.3379,244,207.7322,755,416.24
  经营活动现金流出小计458,931,927.15318,215,108.54164,489,600.04681,849,701.69
  经营活动产生的现金流量净额57,178,624.4366,352,495.7640,513,137.9771,459,925.62
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额84,366.681,666.68-358,946.8
  处置子公司及其他营业单位收到的现金净额---9,484,711.23
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计84,366.681,666.68-9,843,658.03
  购建固定资产、无形资产和其他长期资产支付的现金84,065,451.4478,874,898.3673,881,504.4392,504,619.5
  取得子公司及其他营业单位支付的现金---1,253,289.14
  投资活动现金流出小计84,065,451.4478,874,898.3673,881,504.4393,757,908.64
  投资活动产生的现金流量净额-83,981,084.76-78,873,231.68-73,881,504.43-83,914,250.61
三、筹资活动产生的现金流量:
  吸收投资收到的现金---15,936,918.21
  取得借款收到的现金180,970,998.93113,826,220.6860,503,915.74170,941,038.05
  筹资活动现金流入小计180,970,998.93113,826,220.6860,503,915.74186,877,956.26
  偿还债务支付的现金236,616,038.05158,385,492.543,000,000180,870,000
  分配股利、利润或偿付利息支付的现金12,772,853.868,633,634.874,349,622.1219,872,395.65
  支付其他与筹资活动有关的现金---200,000
  筹资活动现金流出小计249,388,891.91167,019,127.3747,349,622.12200,942,395.65
  筹资活动产生的现金流量净额-68,417,892.98-53,192,906.6913,154,293.62-14,064,439.39
四、汇率变动对现金及现金等价物的影响-12,884.07-13,875.16-3,171.4652,155.92
五、现金及现金等价物净增加额-95,233,237.38-65,727,517.77-20,217,244.3-26,466,608.46
  加:期初现金及现金等价物余额113,185,485.94113,185,485.94113,185,485.94134,643,932.86
  期末现金及现金等价物余额17,952,248.5647,457,968.1792,968,241.64108,177,324.4
补充资料:
  净利润--55,108,349.75--224,426,506.01
  资产减值准备-4,763,014.85-60,301,809.97
  固定资产和投资性房地产折旧-29,189,001.11-53,825,442.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-29,189,001.11-53,825,442.43
  无形资产摊销-4,778,467.4-9,386,215.26
  长期待摊费用摊销-4,949,187.5-12,493,966.58
  处置固定资产、无形资产和其他长期资产的损失-455,864.28-228,016.41
  公允价值变动损失---18,137,228.53
  财务费用-8,324,962.66-21,069,939.46
  投资损失----16,688,228.22
  递延所得税--5,505,377.35--7,566,192.36
  其中:递延所得税资产减少--5,384,622.7--8,348,311.39
    递延所得税负债增加--120,754.65-782,119.03
  存货的减少--19,483,163.2-35,582,034.14
  经营性应收项目的减少--17,180,162.37-92,703,251.47
  经营性应付项目的增加-110,686,032.03-15,849,426.58
  现金的期末余额-47,457,968.17-108,177,324.4
  减:现金的期初余额-113,185,485.94-134,643,932.86
  现金及现金等价物的净增加额--65,727,517.77--26,466,608.46
公告日期2025-10-272025-08-282025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑